Buy weight loss drugs - Acomplia and Rimonabant

A drug that blocks cannabinoid receptors, rimonabant (Acomplia), discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia and under the name as Zimulti in USA.

Click here to buy Acomplia if you are in USA.

Click on the image or on this text to buy Acomplia online if you are in any other country.

What is Acomplia (Rimonabant/Zimulti)

Rimonabant, discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia, and is awaiting approval in the United States. It appears that the FDA will not permit rimonabant to be sold as Acomplia in the U.S., and Sanofi is believed preparing to market it in the United States as Zimulti.

A recent review of four placebo- controlled clinical trials of rimonabant found it produces only moderate weight loss. But even the average 5 percent weight loss seen in the trials after one year of using 5 mg of rimonabant reduced risk factors for type 2 diabetes and cardiovascular disease, according to the October 17, 2006 edition of The Cochrane Library.

A higher dose (20 mg) produced a larger weight loss, almost 11 pounds, as well as a reduction in waist circumference, triglycerides, blood pressure, and raised low HDL cholesterol. These are all risk factors for metabolic syndrome, notes Dr. Aronne.

“In the clinical trial conducted in North America, there was a 39 percent reduction in metabolic syndrome prevalence in the rimonabant group versus 8 percent in the placebo group.” However, the higher dose also produced more side effects such as dizziness, nausea, headache, and depressed mood."

How can I buy Rimonabant/Acomplia/Zimulti ?

Acomplia Rimonabant has been approved as a new weight loss drug in a lot of European countries. It is available in many European countries and can be bought online by the consumers from US.

Buying Rimonabant Acomplia helps you to treat obesity but this new class weight loss drug Rimonabant Acomplia is not yet approved for smoking cessation. It is still waiting for the approval from European union for smoking cessation.


Home Buy Acomplia Zimulti Clinical Trials Acomplia in Europe Rimonabant Online Acomplia Treatement	Buy Acomplia Online A drug that blocks cannabinoid receptors, rimonabant (Acomplia), discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia and under the name as Zimulti in USA. Click here to buy Acomplia if you are in USA. Click on the image or on this text to buy Acomplia online if you are in any other country. What is Acomplia (Rimonabant/Zimulti) Rimonabant, discovered and developed by French pharmaceutical company Sanofi-Synthelabo, is a new drug thas has shown great promise in trials for the treatment of obesity and related metabolic risk factors. Rimonabant is already on the market in Europe, being sold under the trade name Acomplia, and is awaiting approval in the United States. It appears that the FDA will not permit rimonabant to be sold as Acomplia in the U.S., and Sanofi is believed preparing to market it in the United States as Zimulti. A recent review of four placebo- controlled clinical trials of rimonabant found it produces only moderate weight loss. But even the average 5 percent weight loss seen in the trials after one year of using 5 mg of rimonabant reduced risk factors for type 2 diabetes and cardiovascular disease, according to the October 17, 2006 edition of The Cochrane Library. A higher dose (20 mg) produced a larger weight loss, almost 11 pounds, as well as a reduction in waist circumference, triglycerides, blood pressure, and raised low HDL cholesterol. These are all risk factors for metabolic syndrome, notes Dr. Aronne. “In the clinical trial conducted in North America, there was a 39 percent reduction in metabolic syndrome prevalence in the rimonabant group versus 8 percent in the placebo group.” However, the higher dose also produced more side effects such as dizziness, nausea, headache, and depressed mood." How can I buy Rimonabant/Acomplia/Zimulti ? Acomplia Rimonabant has been approved as a new weight loss drug in a lot of European countries. It is available in many European countries and can be bought online by the consumers from US. Buying Rimonabant Acomplia helps you to treat obesity but this new class weight loss drug Rimonabant Acomplia is not yet approved for smoking cessation. It is still waiting for the approval from European union for smoking cessation. click here to buy Acomplia if you are in USA. Click on the image or on this text to buy Acomplia online if you are in any other country.

	We are not associated or authorized by Sanofi - Aventis the manufacturer of Acomplia Rimonabant Zimulti.Rimonabant a diet pill is manufactured by Sanofi-Synthelabo Inc and under the trademark name of Acomplia in Europe and Zimulti in USA. Acomplia/Zimulti/Rimonabant is trademark of Sanofi Aventis.

	\| Site Map\| Links \| Home\|Acomplia Rimonabant \| order Rimonabant \| Acomplia Advantages \| Weight Loss Drugs\| Acomplia Quit Smoking\| How Acomplia Works\|Acomplia Side Effects \|

Buy Acomplia Online

What is Acomplia (Rimonabant/Zimulti)

How can I buy Rimonabant/Acomplia/Zimulti ?